冯崇廉辨治非酒精性脂肪性肝病经验探讨

Abstract
Figure/Table
References (26)
Related Citation (15)

Download: PDF (757 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract With the improvement of people’s living standard and the change of dietary structure, the incidence of non-alcoholic fatty liver disease is increasing year by year, and Chinese medicine has unique advantages in the prevention and treatment of liver disease. This paper summarizes and analyzes the understanding of the etiology and pathogenesis of non-alcoholic fatty liver disease and the thought of syndrome differentiation and treatment of Feng Chonglian, a famous traditional Chinese medicine director in Guangdong Province, in order to provide clinical guidance for syndrome differentiation and treatment of traditional Chinese medicine. Feng Chonglian believes that the traditional Chinese medicine pathogenesis of the disease is mainly liver stagnation and spleen deficiency, phlegm and blood stasis. Clinical expert in the use of Lingnan authentic Chinese herbal medicine, and according to the different stages of the disease syndrome changes, the combination of symptoms, syndrome treatment, combine traditional Chinese and Western medicine. In addition, also pay attention to health education, diet care.

Key words： Feng Chonglian Syndrome differentiation and treatment Non-alcoholic fatty liver disease Clinical experience

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	NIE Zhaoyuan1 FENG Chonglian1 PAN Weiyu2 LIU Jia1 LIANG Weihao3 LUO Meiting1 LI Lingyun1

Cite this article:

NIE Zhaoyuan1 FENG Chonglian1 PAN Weiyu2 LIU Jia1 LIANG Weihao3 LUO Meiting1 LI Lingyun1. Feng Chonglian’s experience in the syndrome differentiation and treatment of non-alcoholic fatty liver disease[J]. 中国医药导报, 2021, 18(22): 145-148.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I22/145

[1] Li B，Zhang C，Zhan YT. Nonalcoholic fatty liver disease cirrhosis：a review of its epidemiology，risk factors，clinical presentation，diagnosis，management，and prognosis [J]. Can J Gastroenterol Hepatol，2018，2018：2784537.
[2] Fan JG，Kim SU，Wong VW. New trends on obesity and NAFLD in Asia [J]. J Hepatol，2017，67（4）：862-873.
[3] Kwak JH，Jun DW，Lee SM，et al. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease：a cross-sectional study [J]. Clin Nutr，2018，37（5）：1550-1557.
[4] Leoni S，Tovoli F，Napoli L，et al. Current guidelines for the management of non-alcoholic fatty liver disease：a systematic review with comparative analysis [J]. World J Gastroenterol，2018，24（30）：3361-3373.
[5] Peleg N，Issachar A，Sneh Arbib O，et al. Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load [J]. JHEP Rep，2019，1（1）：9-16.
[6] 吕婷婷，孙涛，李凯，等.吴明志运用柴胡郁金汤治疗非酒精性脂肪肝的临床经验[J].中国现代医生，2020，58（7）：137-140，145.
[7] 张晨阳，王维，陈文慧.基于气机失调初步探讨非酒精性脂肪肝的病机[J].时珍国医国药，2018，29（5）：1148-1150.
[8] 黄立飞.浅谈中医对非酒精性脂肪肝病因病机的认识及辨证论治[J].中医临床研究，2017，9（9）：88-90.
[9] 冯崇廉.邓铁涛教授应用岭南中草药经验萃谈[J].中华中医药杂志，2005，20（11）：672-673.
[10] 孔祥华.民国岭南草药著作《岭南采药录》与《山草药指南》整理研究[D].广州：广州中医药大学，2011.
[11] 陈文裕，冯崇廉.岭南名中医冯崇廉主任之学术思想浅谈[J].光明中医，2018，33（22）：3312-3314.
[12] 李志国，姜韩雪，焦云涛，等.非酒精性脂肪性肝病中医证型分布的文献分析[J].中华中医药杂志，2017，32（10）：4713-4715.
[13] 李敏谦，林育，项磊，等.基于临床文献的非酒精性脂肪性肝病证候分布规律研究[J].世界中医药，2019，14（1）：6-11.
[14] 张若宣，吕文良.中医治疗非酒精性脂肪肝的研究进展[J].湖北中医药大学学报，2019，21（5）：122-125.
[15] 张声生，李军祥.非酒精性脂肪性肝病中医诊疗专家共识意见（2017）[J].中医杂志，2017，58（19）：1706-1710.
[16] 中华中医药学会脾胃病分会.非酒精性脂肪性肝病中医诊疗指南（基层医生版）[J].中西医结合肝病杂志，2019，29（5）：483-486.
[17] 周盐，蒋雨薇，郑培永.中医药治疗非酒精性脂肪肝病临床研究进展[J].辽宁中医杂志，2019，46（6）：1327-1330.
[18] 黄鸿娜，符燕青，黄晶晶，等.非酒精性脂肪肝中医药治疗进展[J].辽宁中医杂志，2020，47（11）：201-203.
[19] 周宗涛，邓利明，胡丽君，等.非酒精性脂肪肝药物治疗靶点及药物研究进展[J].中国新药杂志，2020，29（12）：1363-1374.
[20] 陈慧基，鲁艳平，李舒，等.苓术二陈汤配合隔姜灸治疗非酒精性脂肪肝患者肝功能的效果分析[J].中国医药科学，2019，9（15）：56-58，78.
[21] 朱丹.名老中医治疗脂肪性肝病的证治规律研究及知识图谱构建探索[D].北京：中国中医科学院，2019.
[22] Rinella ME. Nonalcoholic fatty liver disease：a systematic review [J]. JAMA，2015，313（22）：2263-2273.
[23] Diehl AM，Day C. Cause，pathogenesis，and treatment of nonalcoholic steato-hepatitis [J]. N Engl J Med，2017， 377（21）：2063-2072.
[24] Lu JG，Nguyen L，Samadzadeh S，et al. Expression of proteins upregulated in hepato-cellular carcinoma in patients with alcoholic hepatitis （AH） compared to non-alcoholic steatohepatitis （NASH）：an immunohistochemical analysis of candidate proteins [J]. Exp Mol Pathol，2018， 104（2）：125-129.
[25] 冯崇廉.邓铁涛治疗肝硬化经验[J].中国医药学报，2002， 17（11）：692.
[26] 李阳，王爱文，韩娜娜，等.有氧运动与抗阻运动对非酒精性脂肪肝病疗效差异的Meta分析[J].浙江体育科学，2021，43（1）：75-86.